Auteurs
Analysis
RSA
Racine
Analysis
RSA
Exploration
Accueil
Racine
Racine

Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Gary Maartens »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gary L. Darmstadt < Gary Maartens < Gary Minkley  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000065 (2017) Keertan Dheda [Afrique du Sud] ; Tawanda Gumbo [États-Unis] ; Gary Maartens [Afrique du Sud] ; Kelly E. Dooley [États-Unis] ; Ruth Mcnerney [Afrique du Sud] ; Megan Murray [États-Unis] ; Jennifer Furin [États-Unis] ; Edward A. Nardell [États-Unis] ; Leslie London [Afrique du Sud] ; Erica Lessem [États-Unis] ; Grant Theron [Afrique du Sud] ; Paul Van Helden [Afrique du Sud] ; Stefan Niemann [Allemagne] ; Matthias Merker [Allemagne] ; David Dowdy [États-Unis] ; Annelies Van Rie [Belgique] ; Gilman K H. Siu [République populaire de Chine] ; Jotam G. Pasipanodya [États-Unis] ; Camilla Rodrigues [Inde] ; Taane G. Clark [Royaume-Uni] ; Frik A. Sirgel [Afrique du Sud] ; Aliasgar Esmail [Afrique du Sud] ; Hsien-Ho Lin [Taïwan] ; Sachin R. Atre [Inde] ; H Simon Schaaf [Afrique du Sud] ; Kwok Chiu Chang [République populaire de Chine] ; Christoph Lange [Namibie] ; Payam Nahid [États-Unis] ; Zarir F. Udwadia [Inde] ; C Robert Horsburgh [États-Unis] ; Gavin J. Churchyard [Afrique du Sud] ; Dick Menzies [Canada] ; Anneke C. Hesseling [Afrique du Sud] ; Eric Nuermberger [États-Unis] ; Helen Mcilleron [Afrique du Sud] ; Kevin P. Fennelly [États-Unis] ; Eric Goemaere [Afrique du Sud] ; Ernesto Jaramillo [Suisse] ; Marcus Low [Afrique du Sud] ; Carolina Morán Jara [Pérou] ; Nesri Padayatchi [Afrique du Sud] ; Robin M. Warren [Afrique du Sud]The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
000107 (2017) Tom H. Boyles [Afrique du Sud] ; Adrian Brink [Afrique du Sud] ; Greg L. Calligaro [Afrique du Sud] ; Cheryl Cohen [Afrique du Sud] ; Keertan Dheda [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Guy A. Richards [Afrique du Sud] ; Richard Van Zyl Smit [Afrique du Sud] ; Clifford Smith [Afrique du Sud] ; Sean Wasserman [Afrique du Sud] ; Andrew C. Whitelaw [Afrique du Sud] ; Charles Feldman [Afrique du Sud]South African guideline for the management of community-acquired pneumonia in adults
000124 (2017) Richard A. Murphy [États-Unis] ; Richard Court [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Henry Sunpath [Afrique du Sud]Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps.
000135 (2017) Eric H. Decloedt [Afrique du Sud] ; Maia Lesosky [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; John A. Joska [Afrique du Sud]Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
000367 (2017) Nectarios Sophocles Papavarnavas [Afrique du Sud] ; Kathryn Manning [Afrique du Sud] ; Fahd Conrad [Afrique du Sud] ; Milah Govender [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Factors associated with loss to follow-up after occupational HIV exposure in Cape Town, South Africa: a retrospective cohort study.
000443 (2017) Catherine Orrell [Afrique du Sud] ; Karen Cohen [Afrique du Sud] ; Rory Leisegang [Afrique du Sud] ; David R. Bangsberg [États-Unis] ; Robin Wood [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
000456 (2017) Reneé De Waal [Afrique du Sud] ; Karen Cohen [Afrique du Sud] ; Matthew P. Fox [États-Unis] ; Kathryn Stinson [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Andrew Boulle [Afrique du Sud] ; Ehimario U. Igumbor [Afrique du Sud] ; Mary-Ann Davies [Afrique du Sud]Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.
000653 (2015) Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Liezl Dunn [Afrique du Sud] ; Marla Coetsee [Afrique du Sud] ; Michael Hislop [Afrique du Sud] ; Rory Leisegang [Afrique du Sud] ; Leon Regensberg [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
000812 (2014) Rebecca Tadokera [Afrique du Sud] ; Graeme A. Meintjes ; Katalin A. Wilkinson ; Keira H. Skolimowska ; Naomi Walker ; Jon S. Friedland ; Gary Maartens ; Paul T G. Elkington ; Robert J. WilkinsonMatrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.
000A15 (2013) Phumla Z. Sinxadi [Afrique du Sud] ; Joel A. Dave ; David C. Samuels ; Jeannine M. Heckmann ; Gary Maartens ; Naomi S. Levitt ; C William Wester ; David W. Haas ; Todd HulganMitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study.
000A99 (2013) Julia H. Goedecke [Afrique du Sud] ; Lisa K. Micklesfield ; Naomi S. Levitt ; Estelle V. Lambert ; Sacha West ; Gary Maartens ; Joel A. DaveEffect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women.
000B20 (2013) Helen Van Der Plas [Afrique du Sud] ; Graeme Meintjes ; Charlotte Schutz ; Rene Goliath ; Landon Myer ; Dorothea Baatjie ; Robert J. Wilkinson ; Gary Maartens ; Marc MendelsonComplications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
000D99 (2011) Tom H. Boyles [Afrique du Sud] ; Lynne S. Wilkinson [Afrique du Sud] ; Rory Leisegang [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme
000F32 (2010) Andrew Boulle [Afrique du Sud] ; Gilles Van Cutsem ; Katherine Hilderbrand ; Carol Cragg ; Musaed Abrahams ; Shaheed Mathee ; Nathan Ford ; Louise Knight ; Meg Osler ; Jonny Myers ; Eric Goemaere ; David Coetzee ; Gary MaartensSeven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
001066 (2010) Dominique J. Pepper [Afrique du Sud] ; Suzaan Marais ; Robert J. Wilkinson ; Feriyl Bhaijee ; Gary Maartens ; Helen Mcilleron ; Virginia De Azevedo ; Helen Cox ; Cheryl Mcdermid ; Simiso Sokhela ; Janisha Patel ; Graeme MeintjesClinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.
001340 (2008) Karen Cohen [Afrique du Sud] ; Gilles Van Cutsem [Afrique du Sud] ; Andrew Boulle [Afrique du Sud] ; Helen Mcilleron [Afrique du Sud] ; Eric Goemaere [Afrique du Sud] ; Peter J. Smith [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
001551 (2006) Motasim Badri [Afrique du Sud] ; Susan Cleary [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Jennifer Pitt [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Catherine Orrell [Afrique du Sud] ; Robin Wood [Afrique du Sud]When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A south african cost-effectiveness study
001739 (2002) Gary Maartens [Afrique du Sud] ; Nulda Beyers [Afrique du Sud]Tuberculosis in the tropics
001805 (1999) Motasim Badri [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Rodney Ehrlich [Afrique du Sud]Co-trimoxazole in HIV-1 infection

List of associated KwdEn.i

Nombre de
documents		Descripteur
8Humans
7Adult
6Female
5Anti-HIV Agents (therapeutic use)
5HIV Infections (drug therapy)
5Male
4Anti-HIV Agents (adverse effects)
4Cohort Studies
4Prospective Studies
4South Africa
3CD4 Lymphocyte Count
3Cross-Sectional Studies
3HIV Infections (complications)
3Risk Factors
2AIDS
2Antiretroviral Therapy, Highly Active
2Glomerular Filtration Rate (drug effects)
2HIV Infections (mortality)
2HIV Infections (physiopathology)
2HIV-1
2Incidence
2Middle Aged
2South Africa (epidemiology)
2Sub-Saharan Africa
2Tenofovir (adverse effects)
2Young Adult
1AIDS-Related Opportunistic Infections (drug therapy)
1AIDS-Related Opportunistic Infections (immunology)
1Abidjan
1Absorptiometry, Photon
1Adolescent
1Africa
1African Continental Ancestry Group
1African Continental Ancestry Group (genetics)
1Age
1Aged
1Anglaret
1Anthropometry
1Anti-Inflammatory Agents (administration & dosage)
1Anti-Retroviral Agents (adverse effects)
1Anti-Retroviral Agents (therapeutic use)
1Antiretroviral Therapy, Highly Active (adverse effects)
1Antiretroviral Therapy, Highly Active (methods)
1Antitubercular Agents (therapeutic use)
1Antiviral
1Body Fat Distribution
1Bulk
1Cape town
1Case definition
1Cells, Cultured
1Child
1Community Health Services (standards)
1Comorbidity
1Contraceptive
1Cost efficiency analysis
1Cotrimoxazole
1Countries
1DNA, Mitochondrial (genetics)
1Decrease morbidity
1Drug Interactions
1Early chemoprophylaxis
1Epidemic
1Falciparum
1Fracture
1Gene Expression Regulation (drug effects)
1Genetic Predisposition to Disease
1Genetic Variation
1Genome, Mitochondrial
1HIV (isolation & purification)
1HIV Infections (genetics)
1HIV Infections (immunology)
1HIV Infections (pathology)
1HIV Infections (psychology)
1HIV Infections (virology)
1HIV-1 (drug effects)
1HIV-1 (isolation & purification)
1HIV-1 (physiology)
1HIV-Associated Lipodystrophy Syndrome (etiology)
1HIV-Associated Lipodystrophy Syndrome (genetics)
1Health Services Accessibility (statistics & numerical data)
1Health economy
1Hospital admissions
1Hypertriglyceridemia (etiology)
1Hypertriglyceridemia (genetics)
1Immune Reconstitution Inflammatory Syndrome (drug therapy)
1Immune Reconstitution Inflammatory Syndrome (etiology)
1Immune Reconstitution Inflammatory Syndrome (immunology)
1Increase
1Kidney (drug effects)
1Kidney Diseases (epidemiology)
1Kidney Diseases (etiology)
1Kidney Diseases (physiopathology)
1Lancet
1Leukocytes, Mononuclear (drug effects)
1Leukocytes, Mononuclear (immunology)
1Leukocytes, Mononuclear (microbiology)
1Lithium Compounds (administration & dosage)
1Lithium Compounds (adverse effects)
1Lithium Compounds (pharmacokinetics)
1Lost to Follow-Up

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Gary Maartens" 

HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Gary Maartens" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Gary Maartens
}}
Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024